Related Experiment Video
Updated: Jun 21, 2026
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
STAT3 regulation of glioblastoma pathogenesis
Núria de la Iglesia1, Sidharth V Puram, Azad Bonni
1Department of Pathology, Harvard Medical School, 77 Ave Louis Pasteur, Boston, MA 02115, USA.
Abstract:
Malignant gliomas are the most common primary brain tumors. Despite efforts to find effective treatments, these tumors remain incurable. The failure of malignant gliomas to respond to conventional cancer therapies may reflect the unique biology of these tumors, underscoring the need for new approaches in their investigation. Recently, progress has been made in characterization of the molecular pathogenesis of glioblastoma using a developmental neurobiological perspective, by exploring the role of signaling pathways that control the differentiation of neural stem cells along the glial lineage. The transcription factor STAT3, which has an established function in neural stem cell and astrocyte development, has been found to play dual tumor suppressive and oncogenic roles in glial malignancy depending on the mutational profile of the tumor. These findings establish a novel developmental paradigm in the study of glioblastoma pathogenesis and provide the rationale for patient-tailored therapy in the treatment of this devastating disease.
Insights
Malignant gliomas, including glioblastoma, are aggressive brain tumors. STAT3's role in neural stem cell development offers new therapeutic targets for these challenging cancers.
Area of Science:
- Neuro-oncology
- Developmental Neurobiology
- Cancer Molecular Pathogenesis
Background:
- Malignant gliomas are the most common primary brain tumors and remain incurable with current therapies.
- Understanding the unique biology of these tumors is crucial for developing novel treatment strategies.
- A developmental neurobiological perspective is emerging for glioblastoma research.
Purpose of the Study:
- To investigate the role of signaling pathways in neural stem cell differentiation relevant to glioblastoma.
- To explore the function of the transcription factor STAT3 in glial malignancy.
- To establish a developmental paradigm for glioblastoma pathogenesis.
Main Methods:
- Characterization of molecular pathogenesis of glioblastoma.
- Exploration of signaling pathways controlling neural stem cell differentiation.
- Analysis of the role of STAT3 in glial tumors.
Main Results:
- STAT3 has a dual role (tumor suppressive and oncogenic) in glial malignancy.
- The role of STAT3 is dependent on the tumor's specific mutational profile.
- A novel developmental paradigm for glioblastoma pathogenesis has been identified.
Conclusions:
- STAT3's context-dependent function provides a new understanding of glioblastoma.
- This developmental perspective offers a rationale for patient-tailored therapies.
- Targeting STAT3 based on tumor genetics may improve treatment outcomes for glioblastoma.
